BioAtla BCAB
NASDAQ BCAB
$3.18 +0.00 (+0.00%)
As of: Aug 21, 2026 · 3:59 PM EDT

BioAtla (BCAB) Other Non-Current Liabilities (2021 - 2026)

BioAtla (BCAB) posted quarterly Other Non-Current Liabilities of $842000.0 for Q1 2026, down 56.4% year-over-year from $1.9 million in Q1 2025, and down 76.05% quarter-over-quarter from $3.5 million in Q4 2025.

BioAtla (BCAB) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

BioAtla's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $842000.0 for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities fell 56.4% year-over-year to $842000.0; the TTM figure through Mar 2026 stood at $842000.0 (down 56.4% YoY), while the FY2025 annual figure was $3.5 million, down 82.25% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $842000.0, down from $3.5 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $19.8 million in Q1 2022, with the low at $842000.0 in Q1 2026.
  • The 5-year median for Other Non-Current Liabilities is $19.8 million (2022), against an average of $15.4 million.
  • The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities changed 0.0% in 2022, then sank 90.25% in 2025.
  • BioAtla's Other Non-Current Liabilities stood at $19.8 million in 2022, then changed by 0.0% to $19.8 million in 2023, then changed by 0.0% to $19.8 million in 2024, then slumped by 82.25% to $3.5 million in 2025, then slumped by 76.05% to $842000.0 in 2026.
  • Business Quant data shows BCAB's Other Non-Current Liabilities at $842000.0 in Q1 2026, $3.5 million in Q4 2025, and $19.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 BioAtla 5.41 Mn 5.41 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 19.81 Mn
Mar 31, 2026 842,000.00
Dec 31, 2025 3.52 Mn
Sep 30, 2025 19.81 Mn
Jun 30, 2025 2.23 Mn
Mar 31, 2025 1.93 Mn
Dec 31, 2024 19.81 Mn
Sep 30, 2024 19.81 Mn
Jun 30, 2024 19.81 Mn
Mar 31, 2024 19.81 Mn
Sep 30, 2023 19.81 Mn
Jun 30, 2023 19.81 Mn
Mar 31, 2023 19.81 Mn
Dec 31, 2022 19.81 Mn
Sep 30, 2022 19.81 Mn
Jun 30, 2022 19.81 Mn
Mar 31, 2022 19.81 Mn
Dec 31, 2021 19.81 Mn